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The αLβ2-integrin LFA-1 (CD11a/CD18) is known as an important molecule for leukocyte 
migration. However, the precise role of LFA-1 in the pathogenesis of experimental autoimmune 
encephalomyelitis has so far remained unclear. We describe here the disease development in 
LFA-1-/- mice compared to wild-type controls. Ablation of LFA-1 resulted in more severe EAE 
with increased demyelination and increased numbers of MOG-reactive CD4+ T cells in the CNS. 
However, the production of the pro-inflammatory cytokines IL-17 and IFN-γ was unchanged on 
the level of antigen-specific T cells. Interestingly, LFA-1-deficient mice showed a clearly reduced 
frequency of regulatory T cells in the inflamed CNS.  Moreover, Treg counts in spleens and 
thymi of unimmunized LFA-1-/- mice were lower in comparison to the wild-type controls indicating 
an impairment of Treg generation. In combination, these results suggest a substantial role of 
LFA-1 in Treg generation and subsequent expansion of effector T cells and highlight the 






Experimental autoimmune encephalomyelitis (EAE) is a T cell-mediated inflammatory disease of 
the CNS and serves as an animal model for multiple sclerosis. The autoimmune phenotype can 
be induced in rodents sensitized to proteins like myelin basic protein or myelin oligodendrocyte 
glycoprotein (MOG). The disease is initiated by infiltration of peripheral lymphocytes and 
macrophages into the CNS and is characterized by local inflammation and demyelination. The 
migration of leukocytes into the CNS is facilitated by interactions of cell surface adhesion 
molecules and their endothelial ligands [1]. The family of β2-integrins is involved in leukocyte-
vascular cell interactions as well as in the communication between T cells and antigen 
presenting cells. The αLβ2-integrin LFA-1 (CD11a/CD18) is widely expressed by leukocytes 
including peripheral blood lymphocytes, monocytes, and NK cells [2]. Amongst the members of 
the β2 family of integrins only LFA-1 is expressed by CD4+ T cells and CD4+ CD25+ regulatory 
T cells (Treg) [3]. Interestingly, CD18-deficient mice, which do not express β2-integrins, showed 
an impaired development of thymic and peripheral Treg cells but it remained unclear, which of 
the β2-integrins is responsible for this phenotype [3]. 
 
The function of LFA-1 in EAE has been extensively studied. However, in part controversial and 
conflicting results have been obtained. E.g. treatment with anti-LFA-1 antibodies led to either 
protection against EAE [4] or to more severe disease development [5]. More recently, a 
deficiency for LFA-1 was suggested to dampen EAE upon active induction of an autoimmune 
response [6]. On the other hand, adoptive transfer of wild-type encephalitogenic T cells into 
LFA-1-/- mice profoundly exacerbated the EAE course in comparison to wild-type mice indicating 
an anti-inflammatory role of LFA-1, which would limit disease progression [7]. It remained 
however elusive how LFA-1 exerts its immunosuppressive effects. To gain more insight into 
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LFA-1 functions we further characterized LFA-1-/- mice in comparison to wild-type controls in an 
EAE model. Taken together, we report here that the absence of LFA-1 promotes more severe 
EAE with increased demyelination and increased numbers of inflammatory cells migrating into 
the CNS. Moreover, we demonstrate that the loss of LFA-1 led to impaired generation of Treg 






LFA-1-/- mice develop more severe EAE 
To examine the role of LFA-1 in EAE induction we used a standard mouse model based on the 
subcutaneous immunization of C57BL/6 mice with MOG35-55 peptide emulsified in complete 
Freund´s adjuvant (CFA). The experiment was performed with wild-type (LFA-1+/+), LFA-1-
deficient (LFA-1-/-), and heterozygous mice (LFA-1+/-) as an additional control. LFA-1+/- mice 
express LFA-1 at an intermediate level (data not shown). All experiments were performed with 
littermates to exclude any effects of different C57BL/6 substrains. 
 
Wild-type mice typically developed first clinical signs of EAE between day 10 and 15 and 
reached the peak of disease between day 18 and 23. Clinical signs persisted on the peak level 
for at least 5-7 days before they slowly decreased. Interestingly, LFA-1 knock-out animals 
developed dramatically aggravated clinical signs and reached significantly higher clinical scores 
over the whole observation period (mean cumulative disease score until day 29: 31.4 vs. 14.7, 
p<0.0001, calculated across 3 independent experiments with n=28 or n=27 animals per group). 
A typical experiment is shown in Figure 1 and Table I. In addition, the incidence of EAE through 
day 21 was clearly higher, with 97.5% (+/- 5.6) diseased LFA-1-/- compared to 69.8% (+/- 6.8) 
LFA-1+/+ animals (incidence +/- SEM, calculated from 6 independent experiments with n=7 to 15 
animals per group). In terms of clinical signs LFA-1+/- mice behaved similar to the wild-type mice 
indicating that the intermediate expression of LFA-1 in these mice is sufficient for the biological 
function. 
 
EAE pathology is mainly caused by the infiltration of inflammatory cells into the CNS tissue. This 
local inflammation subsequently leads to demyelination and axonal damage. We therefore 
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analyzed the spinal cord of diseased mice for typical signs of inflammation and demyelination by 
histology (Fig. 2). At the peak of the disease significantly more perivascular infiltrates per spinal 
cord cross section were found in LFA-1-/- mice compared to LFA-1+/+ (LFA-1-/-: 4.4 +/- 1.0; 
LFA-1+/+: 1.16 +/- 0.28; p = 0.024). Similarly, the extent of demyelination was significantly more 
prominent in LFA-1-/- (9.31% +/- 1.9), whereas in LFA-1+/+ almost no demyelination was 
observed (0.76% +/- 0.48; p = 0.004). Moreover, in 3 out of 5 LFA-1-/- mice prominent 
inflammatory infiltrates were detected in cerebellum and/or brain, whereas in the LFA-1+/+ mice 
only sparse inflammatory infiltrates in the cerebellum and/or brain were found (Fig. 2B). In the 
chronic disease phase (day 50 after immunization) the number of inflammatory infiltrates per 
spinal cord cross section was almost unchanged in both animal groups compared to the peak of 
disease (data not shown). Demyelination was still obvious in LFA-1-/- mice (4.57% +/- 1.73) but 
almost completely absent in LFA-1+/+ mice (0.12% +/- 0.33). 
 
Enhanced generation of MOG-specific CD4+ T cells in LFA-1-/- mice 
To further analyze the cellular composition of the infiltrates we prepared single cell suspensions 
from spinal cords by mechanical disruption and enzymatic digestion with collagenase. As 
expected, the total number of cells obtained from spinal cords of LFA-1-/- mice was much higher 
compared to LFA-1+/+ mice (Fig. 3A). To get more information about the composition of the 
infiltrates we used cell subset specific markers in flow cytometry. Next to microglia, CD4+ T cells 
represented the major leukocytic population in the spinal cord. Additionally, we found B cells, 
very few CD8+ T cells, NK cells, NK T cells, γδ T cells, conventional dendritic cells, and 
plasmacytoid dendritic cells. All these latter populations did not differ significantly between 




Autoantigen-specific CD4+ T cells are known to be the major pathogenic factor in EAE [8]. To get 
information not only about total but MOG-specific CD4+ T cells we used a recently established 
system to detect antigen-specific T cells with high sensitivity [9]. The method is based on a 
short-term in vitro restimulation with the cognate antigen and subsequent staining for CD40L 
(CD154). This assay revealed that up to 50% of the infiltrating CD4+ T cells were specific for the 
autoantigen. Importantly, the frequency of MOG-specific CD4+ T cells was approximately twofold 
higher in LFA-1-/- compared to LFA-1+/+ mice (Figure 3A). In combination with the higher 
absolute cell numbers this results in an about fivefold increased number of autoreactive T cells 
in the spinal cord of LFA-1 KO mice, which can easily explain the more aggravated disease. The 
frequency of autoreactive T cells directly correlated with disease severity (r = 0.82, p = 0.0003 
for the experiment shown in Figure 3). 
 
It is important to note that the higher cell number cannot be explained by different kinetics of 
lymphocyte infiltration because comparable results were obtained regardless whether both 
groups were analyzed at the same time point (which was not necessarily the peak of clinical 
signs for both groups) or the peak of the clinical score for individual animals. 
 
As LFA-1 was shown to be involved in lymphocyte migration [10-11] it is tempting to speculate 
that the higher number of MOG-specific T cells in the spinal cord of LFA-1 knock-out mice is the 
result of an enhanced recruitment to the site of inflammation. However, when we used the same 
strategy to identify MOG-specific T cells in secondary lymphoid organs, it turned out that the 
difference in antigen-specific T cells was already established in the spleen and the draining 
lymph nodes (Figure 3B). Therefore, LFA-1 seems to control the generation and not the 




The production of pro-inflammatory cytokines is not altered on the level of antigen-
specific T cells 
Pro-inflammatory cytokines, namely IL-17 and IFN-γ, are well recognized as a major pathogenic 
factor in EAE [8]. As a recent report claimed that LFA-1 critically regulates the development of 
Th17 cells in EAE [6] we analyzed cytokine production by autoreactive CD4+ T cells from 
diseased LFA-1-/- and LFA-1+/+ mice. Cells from spinal cord were restimulated in vitro with MOG-
peptide and stained intracellularly for IL-17 and IFN-γ. As shown in Figure 4, MOG-specific 
T cells from inflamed spinal cords belonged to Th1, Th17, and Th17/Th1 subsets. However, the 
percentage of CD4+ T cells from LFA-1+/+ and LFA-1-/- mice producing these cytokines was 
absolutely comparable on the level of antigen-specific cells. Also the amount of cytokines 
produced did not differ (MFI for IL-17: 20020 +/- 1457 (LFA-1+/+) vs. 21460 +/- 1080 (LFA-1-/-), p= 
0.436; MFI for IFN-γ: 15436 +/- 2127 (LFA-1+/+) vs. 14940 +/- 804 (LFA-1-/-), p = 0.832). Same 
results were obtained for IL-2 and TNF-α. However, it is important to note that the increased 
total number of antigen-specific cells finally results in a higher absolute number of cytokine-
producing CD4+ T cells. Interestingly, there was also no correlation between EAE score of an 
individual animal and cytokine production on the single cell level. Again, only the number of 
infiltrating CD4+ cells correlates with disease severity (see above). 
 
Polyfunctional Th1 cells producing multiple effector cytokines at the same time are thought to be 
particularly destructive in inflammation [12]. Therefore, we also analyzed whether the frequency 
of IL-2, IL-17, IFN-γ double or triple producers was altered between wild-type and knock-out 
mice, but did not find any significant differences (data not shown). Alternatively, a change in Th2 
or anti-inflammatory cytokines could influence the severity of disease. Therefore, we tested for 
production of IL-4 and IL-10. Only very few (< 2%) antigen-specific CD4+ T cells in the spinal 
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cord produced these two cytokines. However, we did not observe any significant differences 
between LFA-1+/+ and LFA-1-/- T cells (data not shown). 
 
To analyze the general capacity of T cells to produce certain cytokines we additionally used an 
antigen-independent stimulation with PMA and ionomycin. Also with this kind of stimulation none 
of the analyzed cytokines differed between knock-out and wild-type mice (data not shown). 
 
Taken together, these results clearly show that loss of LFA-1 does not alter the cytokine pattern 
of autoreactive CD4+ T cells. Therefore, only the increased total number of antigen-specific, 
cytokine-producing cells in LFA-1-/- mice can be accounted for the increased severity of EAE. 
 
Decreased number of regulatory T cells in LFA-1-/- mice 
Regulatory T cells play an important role for the suppression of chronic inflammation [8, 13]. 
They control the expansion as well as function of autoreactive effector T cells. Utilizing 
intracellular staining for the lineage-specific transcription factor FoxP3 we analyzed Tregs in the 
spinal cord of LFA-1-/- and LFA-1+/+ mice after EAE induction. The absolute number of Tregs was 
the same in both groups (Fig. 5). However, the higher number of MOG-reactive T cells in the 
spinal cord of LFA-1-/- mice (Fig. 3A) drastically decreased the ratio of regulatory and effector 
T cells. 
 
To see whether these relative differences in Tregs were the result of MOG-immunization or 
already established in the steady state, we analyzed Tregs in the spleen of non-immunized 
LFA-1+/+ and LFA-1-/- mice. While around 14% of CD4+ T cells in wild-type mice were FoxP3-
positive only approximately 5.5% regulatory T cells were found in LFA-1 knock-out mice (Fig. 
6A). In contrast to the situation in the spinal cord, also absolute numbers of Tregs were 
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diminished whereas numbers of CD44high CD62Llow effector-memory phenotype T cells were 
unaltered in steady state (Fig. 6A). To get more information about the phenotype of Tregs in 
LFA-1 KO mice we analysed several markers defining subsets or which are known to be 
important for the function of Tregs, such as CTLA-4, GITR, OX40, and 4-1BB (supplementary 
Fig. S1). However, we could not find any differences. 
 
Generally, a diminished population of Tregs can be explained by either reduced generation in 
the thymus or altered survival and homeostasis in the periphery. To discriminate these two 
possibilities we directly examined Tregs in the thymus of LFA-1-/- and LFA-1+/+ mice. As reported 
earlier [14], there were neither obvious differences in size and cellularity of the thymus nor in the 
distribution of CD4/CD8 thymic subsets (Figure 6B and data not shown). Also histologically the 
thymus did not display any abnormalities. However, when we analyzed the frequency of FoxP3+ 
T cells in the different thymic subsets we found a significant reduction of Tregs in the CD4+ 
single-positive subset of LFA-1-/- mice (Fig. 6B). 
 
Taken together, our results clearly show that a reduced generation of naturally occurring Tregs 
in the thymus of LFA-1 knock-out mice results in a substantial lower frequency of Tregs in 
secondary lymphoid organs. 
 
Partial depletion of Tregs in WT mice resembles the phenotype of LFA-1 KO mice in EAE 
To test whether the reduced number of regulatory T cells in LFA-1 KO mice alone would be 
sufficient to explain the aggravated course of EAE we suboptimally depleted Tregs from WT 
mice. This was achieved by a single injection of the anti-CD25 mAb PC61. As shown in 
supplementary Fig. 2 this treatment resulted in a Treg frequency resembling LFA-1-/- mice. WT 
mice, PC61-depleted WT mice, and LFA-1 KO mice were immunized with MOG-peptide. Fig. 7 
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shows that the P61-depleted animals developed EAE scores absolutely comparable to LFA-1-/- 





Until now the exact role of LFA-1 in the pathogenesis of EAE is still elusive. There are several 
early studies using blocking monoclonal antibodies against LFA-1 which provided conflicting 
results. In one case this treatment resulted in a clear amelioration [4] while Welsh et al. [5] 
reported an augmentation of EAE. In a third study [15] the animals simply died from the injection 
of the antibody. However, since no F(ab´)2 fragments of the LFA-1 antibody were used it is 
unclear whether the observed effects were the result of a LFA-1 blockade, depletion of LFA-1 
expressing cells, or signals via inhibitory Fc receptors. Two more recent studies used LFA-1 
knock-out mice. Wang et al. [6] observed a diminished EAE induction in LFA-1-/- mice and 
attributed this to an impaired generation of Th17 cells. However, the authors neither analyzed 
antigen-specific T cells nor did they isolate T cells from the CNS. A further potential problem with 
this study may be due to the choice of control mice. LFA-1 KO mice were on a C57BL/6J 
background and bred in the authors` own facility whereas C57BL/6NCrl WT mice from a 
commercial breeder were used as control. In contrast, we used littermate LFA-1-/-, LFA-1+/-, and 
LFA-1+/+ mice, to avoid such ambiguities. In the second study, Dugger et al. [7] also reported 
diminished disease of LFA-1 KO mice in an active EAE model. However, in an adoptive transfer 
EAE model injection of wild-type encephalitogenic T cells into LFA-1-/- recipients resulted in a 
fatal EAE disease course. At that time the authors could not find an explanation for this different 
outcome. Our results now suggest that the reduced number of Tregs in the LFA-1-/- recipients 
most likely resulted in enhanced expansion and activation of the transferred autoreactive T cells. 
 
In our study ablation of LFA-1 results in an exacerbated disease in mice sensitized to a MOG-
derived peptide. We could correlate this augmented response to a defect in thymic Treg 
generation in LFA-1 knock-out mice. The reduced suppression by Tregs most likely leads to an 
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enhanced generation of MOG-reactive T cells which then infiltrate the CNS. Interestingly, in this 
particular setting LFA-1 deficiency did not directly affect T cell effector function as determined by 
cytokine production on the single cell level. This is a quite unexpected finding given the reports 
showing that LFA-1 enhances T cell activation [16-17]. Obviously, in this specific EAE model the 
effect of LFA-1 on Treg generation is more dominant and determines the final biological 
outcome. We recently reported a similar finding for the inducible costimulator ICOS which 
augments the long-term survival of effector as well as regulatory T cells [18]. Dependent on the 
biological context, ICOS costimulation can result in pro-inflammatory as well as anti-
inflammatory effects. Now, LFA-1 seems to be another example of such a Janus-faced immune 
regulator. 
 
Involvement of Tregs in the pathogenesis of EAE has been documented in numerous studies. 
Depletion of CD25+ cells in vivo usually resulted in an exacerbation of the disease whereas 
transfer of high numbers of regulatory T cells protected animals from EAE (reviewed in [13]). 
The general role of ß2-integrins for the development of Tregs have been first shown by Marski et 
al. [3] who observed a substantial reduction of Tregs in CD18 knock-out mice, which lack LFA-1 
(CD11a/CD18), Mac-1 (CD11b/CD18), integrin αX (CD11c/CD18), and CD11d/CD18 at the 
same time. A very recent study reported reduced numbers of Tregs in secondary lymphoid 
organs of LFA-1 knock-out mice [19]. However, in contrast to our results they did not detect any 
differences in the thymus.  
 
A number of studies suggested that Tregs exert their suppressive function on effector T cells 
indirectly by modifying the function of antigen-presenting dendritic cells. Interestingly, a recent in 
vitro study showed that LFA-1 is important for the formation of dendritic cell/Treg aggregates 
because LFA-1-/- Tregs were no longer able to inhibit the maturation of cocultured dendritic cells 
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[20]. Similar effects were also observed in a mixed human/mouse suppression system [21]. We 
show here that LFA-1 deficiency results in a reduced Treg/effector cell ratio in the inflamed CNS. 
The reduction in Tregs was already established in the spleen and thymi of unimmunized LFA-1-/- 
mice. Hence, besides a possible functional impairment of Tregs lacking LFA-1 these results 
indicate a more fundamental role for LFA-1 in generation of FoxP3+ Tregs in the thymus. 
ICAM-1, a ligand of LFA-1, is expressed on thymic stromal cells [22]. Therefore, LFA-1 
potentially increases the physical contact between thymocytes and stromal cells resulting in 
enhanced T cell receptor triggering. Increased T cell receptor signalling during thymocyte 
selection favours the generation of naturally occurring Tregs [23], which would explain the 
contribution of LFA-1 to the generation of naturally occurring Tregs. 
 
So far, LFA-1 has been mainly recognized as a molecule regulating the migration of 
lymphocytes. Generally, the migration of LFA-1-deficient T cells to the peripheral lymph nodes is 
impaired, resulting in significantly smaller lymph nodes [10, 14]. However, upon immunization 
with MOG-peptide we observed that these differences in cellularity in lymph nodes between wild-
type and LFA-1 knock-out mice is more or less levelled out (data not shown). In the context of 
EAE and transendothelial migration, Laschinger et al. [11] demonstrated that encephalitogenic 
T cells do not use LFA-1 for the initial adhesion to the endothelium of the blood/brain barrier. 
Instead, LFA-1 was involved in the later phases of migration into the CNS parenchyma. 
However, it should be noted that these results were obtained for the healthy spinal cord and that 
the role of LFA-1 for migration could be different during later stages of an EAE disease, in which 
other integrin interactions may compensate for the lack of LFA-1. In our study, we did not directly 
address the question of lymphocyte migration via the blood/brain barrier. However, the 
observation that the frequency of MOG reactive CD4+ T cells in LFA-1-/- mice is already higher 
outside the CNS suggests an impaired suppression of effector T cells by Tregs rather than an 
15 
 
altered migration as cause for the higher ratio of effector versus regulatory T cells in the inflamed 
CNS in LFA-1-/-.  
 
Overall, the exacerbated EAE in the absence of LFA-1 seems to be due to the impaired 
suppression of autoantigen-specific effector T cells by Tregs, which in LFA-1-/- mice show a 
more extensive expansion in secondary lymphoid organs upon immunization with the MOG-
peptide. Not surprisingly, this enhanced generation of autoreactive CD4+ T cells results in an 
increased infiltration of pathogenic MOG-specific T cells into the CNS and consequently in more 
severe demyelination and inflammation. In addition, our Treg depletion experiment shows that 
the reduced number of Tregs alone is sufficient to explain the aggravated EAE course. 
Therefore, additional functional defects of the Tregs appear to be unlikely but can, on the other 
hand, not totally be excluded.  Taken together, our results point towards a crucial involvement 
for LFA-1 in Treg homeostasis and highlight the importance of Tregs in limiting EAE. Future 
work needs to determine, how Treg generation depends on the presence of LFA-1. 
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Materials and methods 
 
Mice 
LFA-1-deficient mice [24] were obtained from the Jackson Laboratories and were backcrossed 
to C57BL/6 for 13 generations. We further crossed them with C57BL/6 wild type mice and used 
littermates of LFA-1+/- inter-se matings for the experiments. Animal handling and experiments 
were conducted according to the German animal protection laws and approved by the 
responsible governmental authority. 
 
EAE induction 
For EAE induction, six to ten weeks old mice were anaesthetized with ketamine (94 mg/kg body 
weight) and xylazine (6.25 mg/kg) and immunized subcutaneously at two sites of the back close 
to inguinal lymph nodes with 200 µg myelin oligodendrocyte glycoprotein 35-55 (MOG35-55) in 
CFA (EAE Induction Kit™, MOG35-55/CFA Emulsion PTX (3.75x), Hooke Laboratories). Directly 
after immunization mice received a first dose of 400 ng pertussis toxin intraperitoneally followed 
by a second injection the day after. After one week mice were scored daily for clinical signs 
according to the following scale: 0 = no obvious changes in motor functions; 1 = limp tail; 2 = 
limp tail and weakness of hind legs; 3 = limp tail and complete paralysis of hind legs; 4 = limp 
tail, complete hind leg and partial front leg paralysis; 5 = complete hind and complete front leg 
paralysis. 
 
Depletion of regulatory T cells 
8 days prior induction of EAE mice were treated with 500 µg anti-CD25 (clone PC61.5) i.p. The 
antibody preparation was controlled to contain less than 0.1 ng endotoxin/mg of protein by 





Mice were perfused under deep anaesthesia through the left cardiac ventricle with PBS followed 
by 4% paraformaldehyde (PFA). Brain and spinal cord were removed, post-fixed in PFA over 
night and embedded in paraffin. Five µm thick sections were stained for haematoxylin-eosin, 
Luxol Fast Blue (LFB) / periodic acid-Schiff (PAS), and Bielschowsky’s silver impregnation. 
Immunohistochemistry was performed with an avidin-biotin technique. For immunohisto-
chemistry sections were deparaffinised and intrinsic peroxidase activity was blocked by 
incubation with 5% H2O2 in PBS for 20 min. Non-specific antibody binding was inhibited with 
10% FCS in PBS for 25 min. Macrophages/microglial cells were detected using an anti-Mac-3 
antibody (BD Biosciences) with biotinylated anti-mouse Ig (GE Healthcare) as secondary 
reagent. Staining was developed using the avidin-biotin technique and 3,3’-diaminobenzidine as 
chromogen. 
To quantify the demyelinated area transverse spinal cord cross sections from all regions of the 
spinal cord were analyzed (between five and eleven cross sections per animal). The 
demyelinated area was measured in sections stained for LFB/PAS, and expressed as 
percentage of total white matter. For statistical analysis the mean per animal was calculated. 
Similarly, the numbers of inflammatory infiltrates were counted in all transverse spinal cord 
sections and the mean per section was calculated. 
 
Cell preparation 
To prepare single cell suspensions from spleen, peripheral lymph nodes, or thymus organs were 
cut into small pieces and meshed through a sieve. For cell preparation from spinal cords mice 
were perfused with 25 ml PBS via the left cardiac ventricle under deep anaesthesia. The spinal 
cord was removed and collected in cold medium (RPMI 1640, 0.5% BSA). A single cell 
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suspension was prepared using the gentleMACS dissociator (Miltenyi Biotec) and digestion with 
0.5 mg/ml collagenase D and 20 µg/ml DNase I (both from Roche) for 30 min at 37°C. To stop 
digestion 10 mmol EDTA was added for the last 5 min. To remove residual pieces of tissue the 
suspension was filtered through a 100 µm filter. Cells were counted using a Guava PCA 
capillary flow cytometer and ViaCount solution (Millipore). 
 
Flow cytometry 
Single cell suspensions from spinal cord, lymph nodes, spleen, or thymus were suspended in 
staining buffer (PBS, 2.5% FCS, 0.1% NaN3, 20 µg/ml 2.4G2 (anti-FcγRII/III)) and incubated on 
ice with different combinations of the following fluorophore-conjugated mAb: Pacific Blue-
conjugated KT3 (anti-CD3), PE- or PE-Cy7-conjugated GK1.5 (anti-CD4), Alexa Fluor 700-
conjugated 53-6.72 (anti-CD8), FITC- or PE-conjugated IM7.8.1 (anti-CD44), Pacific Orange-
conjugated RA3-6B2 (anti-B220), FITC- or PE-Cy7-conjugated MEL-14 (anti-CD62L), 
Allophycocyanin-Cy7-conjugated 30-F11 (anti-CD45; BioLegend), Allophycocyanin-Alexa Fluor 
750-conjugated 53-6.7 (anti-CD8; eBioscience), and PE-conjugated 17B5 (anti-4-1BB; 
eBioscience), Ox-86 (anti-OX40), DTA-1 (anti-GITR; eBioscience), UC10-4F10 (anti-CTLA-4), 
2E4 (anti-CD25). Antibodies from non-commercial sources were purified from hybridoma 
supernatants and coupled to the respective fluorophore by standard procedures. For intracellular 
staining of FoxP3, Alexa Fluor 647-conjugated FJK-16s and a commercial buffer set (both from 
eBioscience) were used. Isotype controls were used to control specificity of staining. To 
discriminate dead cells, either DAPI was added to live cells immediately before analysis or cells 
were incubated on ice for 25 min with 0.67 mM Pacific Orange succinimidyl ester (Invitrogen) 
prior to fixation (modified protocol from [25]). 1x105 to 2x106 cells were analyzed on a LSR II flow 
cytometer (405 nm, 488 nm, and 633 nm excitation; BD Biosciences). Data were further 
analyzed with FlowJo Software (Treestar). Analysis gates were set on live cells defined by 
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scatter characteristics and exclusion of DAPI or Pacific Orange positive cells. Doublets were 
excluded using FSC and SSC height vs. area characteristics.  
 
Analysis of antigen-specific cells and cytokine production 
For analysis of antigen-specific cells and cytokine production cells were suspended at 5x106 per 
ml in medium (RPMI 1640, 10% FCS) and restimulated with 25 µg/ml MOG35-55 (MoBiTec) for 
6 h at 37°C. After 2 h of culture, 5 µg/ml brefeldin A (Sigma) was added. 
After staining of cell surface antigens and live/dead discrimination with Pacific Orange, cells 
were fixed with formaldehyde and permeabilised with saponin (buffer set from eBioscience). 
Unspecific binding sites were blocked with 100 µg/ml 2.4G2 and 50 µg/ml purified rat Ig (Nordic) 
and cells were stained intracellularly with the following fluorophore-conjugated mAb: FITC-
conjugated TC11-18H10 (anti-IL-17) or MP6-XT22 (anti-TNF-α), PE-conjugated MR1 (anti-
CD40L; all from BioLegend), digoxygenin-conjugated JES6-5H4 (anti-IL-2) or JES5-2A5 (anti-
IL-10), Pacific Blue conjugated AN18.17.24 (anti-IFN-γ) or 11B11 (anti-CD4). As secondary 
reagent Alexa Fluor 647-conjugated anti-digoxygenin (Roche) was used. To determine the 
individual staining background of the anti-cytokine mAb a control sample was included where 
cells were preincubated with a 100-fold excess of unlabeled antibody (cold blocking control). 
Cells were further analyzed by flow cytometry as described above. 
 
Statistical analysis 
All data were analyzed using GraphPad Prism software using either Student´s t test to determine 
differences between two groups, Kruskal-Wallis test for the scoring curves, or Pearson test for 
correlation of two parameters. Variation within experimental groups is reported as SEM. 
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Figure 1. Clinical course of EAE development. 
LFA-1-/- (n=13), LFA-1+/+ (n=14), and LFA-1+/- (n=12) mice were immunized with CFA emulsified 
MOG-peptide subcutaneously. Animals were scored daily for clinical signs. Shown is the mean 
clinical score for each group (± SEM). LFA-1-/- mice developed significantly higher disease 
scores compared to LFA-1+/+ mice (p=0.0053, t-test; p=0.0035, Kruskal-Wallis test). A 
representative experiment out of seven independent experiments is shown. 
 
Figure 2. Histological analysis of spinal cord and brain inflammation and demyelination. 
Spinal cords and brains from LFA-1+/+ and LFA-1-/- mice were removed at the peak of EAE 
disease for each group and embedded in paraffin. Transverse sections from all regions of the 
spinal cord and brain were stained with Luxol Fast Blue / periodic acid-Schiff reagent or Mac-3 
immunohistochemistry (representative stainings are shown in B).  
(A) To quantify inflammation the numbers of Mac-3 positive infiltrates were counted in all spinal 
cord sections and the mean per transverse section was calculated for each animal. In addition, 
the demyelinated area was measured and expressed as percentage of total white matter. Data 
were analyzed using Student´s t test. 
 
Figure 3. Analysis of MOG-specific CD4+ T cells. 
(A) Analysis of lymphocyte infiltration in the spinal cord. At the peak of disease (day 21) spinal 
cords from LFA-1+/+ and LFA-1-/- mice were removed and single cell suspensions prepared. The 
upper left panel shows total numbers of infiltrating cells per spinal cord (representative 
experiment out of four). For analysis of antigen-specific CD4+ T cells, total cells were stimulated 
in vitro with MOG-peptide for 6 h and stained for CD45, CD4, CD8, and intracellularly for CD40L 
and IFN-γ. Typically, approximately 80% of isolated cells were CD45high in both groups. The 
25 
 
representative flow cytometric staining shows that not only the overall frequency of CD4+ T cells 
(gated on live CD45high cells) is higher in LFA-1-/- mice but also the frequency of antigen-specific 
T cells (CD40L+) within the CD4+ population. As the combined effect the two plots on the right 
show the total number of MOG-specific CD4+ T cells and their frequency of live CD45high cells. 
Shown is a representative experiment out of two with n=14 animals in each group. (B) Analysis 
of antigen-specific CD4+ T cells from spleen and lymph nodes. Same animals and same strategy 
to identify MOG-specific CD4+ T cells as in panel A. Data were analyzed using Student´s t test. 
 
Figure 4. Cytokine production by MOG-specific CD4+ T cells in the spinal cord. 
Cells from inflamed spinal cords (day 21) were stimulated in vitro with MOG-peptide for 6 h and 
stained for CD45, CD4, and intracellularly for CD40L, IFN-γ, TNF-α, IL-2, and IL-17. The upper 
panel shows a representative flow cytometric analysis for the coexpression of IL-17 and IFN-γ by 
live CD45high CD4+ CD40L+ MOG-specific T cells from a LFA-1+/+ and LFA-1-/- mouse. The lower 
panel shows IFN-γ, IL-17, TNF-α, and IL-2 expression by MOG-specific CD4+ T cells for all 
animals from a representative experiment out of two. Data were analyzed using Student´s t test. 
 
Figure 5. Regulatory T cells in the spinal cord. 
Cells were prepared from spinal cords of LFA-1+/+ and LFA-1-/- mice at day 16 after EAE 
induction (peak of disease). To quantify Tregs by flow cytometry cells were stained for CD45, 
CD3, CD4, CD8, and intracellular FoxP3. Exemplary flow cytometric data (gated on live CD45high 
CD3+ T cells) and results for all animals from a representative experiment out of four are shown. 






Figure 6. Regulatory T cells in spleen and thymus. 
Flow cytometric analysis of (A) spleen and (B) thymus from unimmunized LFA-1+/+ and LFA-1-/- 
mice. Cells were stained for CD45, CD3, CD4, CD8, and intracellular FoxP3 and analyzed by 
flow cytometry. Shown is the gating strategy to identify regulatory T cells. Graphs represent (A) 
the proportion of FoxP3+ cells within the CD4+ subset and their absolute number per spleen. In 
addition, the absolute numbers of effector-memory (CD44highCD62Llow) and naive 
(CD44highCD62Llow) T cells are shown (B) the proportion of FoxP3+ cells within the subset of CD4 
single-positive thymocytes. Representative results out of two independent experiments. Data 
were analyzed using Student´s t test. 
 
Figure 7. Clinical course of EAE with Treg-depleted mice. 
LFA-1-/- (n=7), LFA-1+/+ (n=7), and Treg-depleted LFA-1+/+ (n=7) mice were immunized with CFA 
emulsified MOG-peptide subcutaneously. Animals were scored daily for clinical signs. Shown is 
the mean clinical score for each group (± SEM). LFA-1-/- and PC61-depleted mice developed 
significantly higher disease scores compared to LFA-1+/+ mice (p=0.014 and p<0.0001, 
respectively; Student´s t test. 
 
 
Table I. Clinical course of EAE. Additional information for the experiment shown in Fig. 1 
 LFA-1+/+ LFA-1+/- LFA-1-/- 
Disease incidence (d21) 10/14 9/12 13/13 
Disease incidence (d32) 13/14 9/12 13/13 
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Supplementary Figure 1. Characterization of Tregs and non-
Tregs in WT and LFA-1 KO mice. 
Splenocytes from unimmunized LFA-1+/+ (closed symbols) and
LFA-1-/- mice (open symbols) were stained for CD3, CD4,
intracellular FoxP3, and the indicated cell surface markers and
analyzed by flow cytometry. Shown is the proportion of marker





















Supplementary Figure 2. Depletion of regulatory T cells. 
Tregs were depleted by a single injection of anti-CD25 mAb 
(clone PC61.5) 8 days before analysis. Spleen and lymph 
node cells from WT, LFA-1 KO, and PC61-depleted mice were 
analysed by flow cytometry for FoxP3 positive cells. 
